Fatty acids | Sex [β/OR (95% CI)] | Age [β/OR (95% CI)] | ||||
---|---|---|---|---|---|---|
(g/d) | Men | Women | P for interaction | < 60 years | 60–80 years | P for interaction |
AAC score | ||||||
Total SFAs | 0.01 (0.01, 0.03)* | 0.01 (0.00, 0.02)* | 0.561 | 0.01 (0.01, 0.03)* | 0.02 (-0.01, 0.04) | 0.385 |
Total MUFAs | 0.01 (0.00, 0.03) | 0.01 (0.01, 0.02)* | 0.682 | 0.01 (0.01, 0.03)* | 0.01 (0.01, 0.02)* | 0.699 |
Total PUFAs | 0.01 (-0.00, 0.03) | 0.02 (0.01, 0.03)* | 0.209 | 0.01 (-0.00, 0.02) | 0.02 (0.01, 0.04)* | 0.310 |
Omega-3 FA | -0.06 (-0.09, -0.03)* | -0.04 (-0.07, -0.01)* | 0.098 | -0.05 (-0.09, -0.01)* | -0.07 (-0.11, -0.03)* | 0.055 |
Omega-6 FA | -0.08 (-0.12, -0.04)* | -0.09 (-0.16, -0.02)* | 0.236 | -0.07 (-0.11, -0.04)* | -0.10 (-0.16, -0.03)* | 0.046* |
Severe AAC | ||||||
Total SFAs | 1.01 (1.00, 1.02)* | 1.01 (1.00, 1.03)* | 0.188 | 1.02 (1.01, 1.03)* | 1.01 (1.00, 1.03)* | 0.342 |
Total MUFAs | 1.01 (1.00, 1.03)* | 1.01 (1.00, 1.03)* | 0.872 | 1.01 (1.00, 1.03)* | 1.02 (1.00, 1.04)* | 0.481 |
Total PUFAs | 1.02 (1.00, 1.04)* | 1.02 (1.01, 1.03)* | 0.653 | 1.03 (1.01, 1.04)* | 1.02 (1.01, 1.03)* | 0.098 |
Omega-3 FA | 0.99 (0.97, 1.00) | 0.98 (0.97, 0.99)* | 0.212 | 0.99 (0.98, 1.00)* | 0.95 (0.92, 0.98)* | 0.003* |
Omega-6 FA | 0.95 (0.92, 0.99)* | 0.97 (0.94, 0.99)* | 0.070 | 0.96 (0.93, 0.99)* | 0.92 (0.87, 0.98)* | < 0.001* |